Under construction – not a live service
Sign in
Taking people in NorwayPhase 1

Tests stool bacteria transplant in people with Alzheimer's disease

Tests a transplant of donor stool bacteria in adults with Alzheimer's disease.

Plain-language title generated from the registry record
Registry title: Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study

Key facts

Where
Tromsø, NorwaySee the site
Phase
Phase 1

Where in Norway

  • University Hospital of North Norway, TromsøTromsø, NorwayTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital of North Norway
Trial code
NCT07332260
Record updated
22 April 2026
Original description
The goal of this study is to assess the feasibility and safety of faecal microbiota transplantation for Alzheimer's disease.Read full original descriptionShow less

Alzheimer's Disease and Faecal Microbiota Transplantation

The goal of this study is to assess the feasibility and safety of faecal microbiota transplantation for Alzheimer's disease.

Inclusion: Alzheimer's dementia mild to moderate stage; Presence of Alzheimer pathology core 1 biomarkers as defined by National Institute on Aging-Alzheimer's Association (NIA-AA) criteria (2024); Capable of giving informed consent.

Exclusion: Receiving biological/antibody treatment; History of seizure disorder; History of brain tumour or intracranial bleed; Major psychiatric disorder such as schizophrenia, bipolar disorder, or major depressive disorder; Decompensated heart disease; Malignancy; Inflammatory bowel disease; Contraindications for colonoscopy examination; Contraindications for Magnetic Resonance Imaging (MRI); Life expectancy < 1 year; Clinical frailty scale 7 or more; Alcohol or substance abuse; Current use of anticoagulant treatment (dual acting oral anticoagulant or warfarin); Pregnant or planning pregnancy; Colonic adenomas over 1 cm, tumours or signs of active colitis on colonoscopy; Status after colectomy or hemicolectomy; Immunocompromised individual.

ClinicalTrials.gov NCT07332260